| abstract |
The present invention relates to novel beta agonists of formula (I).n n n Formula In n n n n n n n In Formula I above,n n n R 1 and R 2 are as described in the claims and the specification.n n n The invention also relates to tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures, prodrugs or salts of compounds of formula (I), in particular their physiologically acceptable with inorganic or organic acids or bases. Salts, processes for the preparation of compounds of formula (I) and their use as medicaments. |